PharmaResearch Launches ‘Rientox’ in Thailand with TAS Symposium

PharmaResearch, a leader in regenerative medicine, announced on the 30th that it held the ‘Total Aesthetic Solution Symposium’ (TAS Symposium) at the Kempinski Hotel in Thailand on the 28th, celebrating the launch of its botulinum toxin A product, ‘Rientox’. The event saw participation from approximately 300 local healthcare professionals, reflecting significant interest in the new offering.

The Symposium coincided with Rientox's approval and product launch in Thailand and served as a platform to introduce additional products, including the polynucleotide (PN)-based skin booster ‘Rejuran’, HA (hyaluronic acid) filler ‘Cleviel’, and PN-based intra-articular injection ‘Conjuran’. This strategic approach exemplifies PharmaResearch's commitment to delivering a comprehensive aesthetic solution.

By leveraging the established success of Rejuran and Cleviel in the Thai market, the introduction of Rientox aims to enhance treatment options across various aesthetic areas such as skin improvement, volumization, and contouring. The integrated approach interlinks the mechanisms of the products with their treatment objectives, equipping local medical practitioners with a wider range of selections.

In addition, the event highlighted Conjuran, underscoring PharmaResearch's direction towards expanding its business beyond aesthetics into the medical sector. This diversification strategy indicates a robust response to evolving market needs while aligning with broader healthcare trends.

A representative from PharmaResearch commented, “Thailand has proven to be a key market for our products, particularly with Rejuran and Cleviel. Through the launch of Rientox, we aim to strengthen synergies with our existing portfolio and provide a more complete integrated solution.”

This launch signifies a pivotal shift in PharmaResearch's business model, emphasizing not only aesthetic solutions but also an expansion into broader medical applications. It illustrates a response to the growing demand for holistic treatment options in the beauty and healthcare sectors, positioning the company to capitalize on emerging trends.